Maintaining high levels of vitamin D can optimize therapy for osteoporosis
Patients who have osteoporosis may buy Actonel to reduce the symptoms of their disease.
Patients who have osteoporosis may buy Actonel to reduce the symptoms of their disease. Purchasing this product from a Canadian internet pharmacy can result in significant cost savings for these individuals, as the bone disorder can be an expensive condition to treat.
According to a study that was presented at the annual meeting of the Endocrine Society in Boston this week, people with osteoporosis should maintain high levels of vitamin D in order to optimize drug therapy for their illness.
The Institute of Medicine recommends a limit of 20-30 nanograms per milliliter (ng/ml) of vitamin D intake each day, but the researchers discovered that osteoporosis patients who have a circulating level higher than this may experience a seven-fold greater likelihood of having a favorable outcome.
"You are seven times more likely to respond to bisphosphonates if your 25-Hydroxy vitamin D level is 33 ng/ml and above," said lead author Richard Bockman. "If you want to see a particular outcome from this treatment, then maybe 20 to 30 is not appropriate. When you see a seven times greater effect, that is pretty impressive."
The team reported that more than 20 million individuals in the U.S. take bisphosphonates to maintain their skeletal health and reduce the risk of fractures caused by osteoporosis.
|
